हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Katsuhiro Toda
A 58-year-old male (162.1 cm, 76.8 kg, body mass index 29.2) suffered from intermittent claudication. At the initial visit, walking 10-100 meters caused pain in lateral part of the right lower limb, resulting in inability to walk. Xray showed mild forward slip of the fifth lumbar vertebra, however, MRI did not show narrowing of the lumbar canal. He could walk at least 1 km without pausing with Neurotropin®. If he failed to take Neurotropin®, he suffered from pain of the right lower limb. Four months later, he weighed 71.0 kg. He discontinued Neurotropin®, however, he did not feel pain during walking.
In the patient, weight reduction eliminated intermittent claudication without effective medicine. It is unclear whether the patient suffered from lumbar canal stenosis (LCS). Weight reduction is one of the first-line treatments in obese or overweight patients with LCS. Weight reduction is a safe and inexpensive treatment. Even if weight reduction does not alleviate symptoms, it improves overall health in former obese or overweight persons. However, we should not recommend weight reduction to patients whose first priority is maintaining of the amount of food.